CIP
PAHC icon

Champlain Investment Partners’s Phibro Animal Health PAHC Stock Holding History

Champlain Investment Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-190,760
Closed -$3.56M – 148
2016
Q2 		$3.56M Sell
190,760
-201,330
-51% -$4.2M 0.06% 117
2016
Q1 		$10.6M Sell
392,090
-44,435
-10% -$1.27M 0.19% 116
2015
Q4 		$13.2M Sell
436,525
-4,675
-1% -$150K 0.22% 118
2015
Q3 		$14M Sell
441,200
-21,810
-5% -$796K 0.24% 114
2015
Q2 		$18M Buy
463,010
+2,395
+0.5% +$82.6K 0.28% 108
2015
Q1 		$16.3M Buy
+460,615
New +$14.8M 0.28% 110

Other funds holding PAHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Champlain Investment Partners's PAHC Position: Q3 2016 in Review

Champlain Investment Partners sold out of Phibro Animal Health (PAHC) in Q3 2016, closing a stake of 190,760 shares — an estimated $3.56M sold.

Champlain Investment Partners first reported a position in PAHC in Q1 2015 and held it in 6 quarters. The position peaked at $18M in Q2 2015. 122 funds tracked by Wall St. Rank hold PAHC as of Q3 2016.

  • Champlain Investment Partners reported no remaining Phibro Animal Health position as of Q3 2016 after selling out during the quarter.
  • Champlain Investment Partners sold 190,760 Phibro Animal Health shares in Q3 2016, an estimated $3.56M.
  • Champlain Investment Partners first reported a position in Phibro Animal Health in Q1 2015 and held it in 6 quarters.
  • Champlain Investment Partners's Phibro Animal Health position peaked at $18M in Q2 2015.
  • 122 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2016.

Based on Champlain Investment Partners's 13F filing for Q3 2016, filed 14 Nov 2016.